cagrilintide dosage guideline Chart (5mg Vial) Cagrilintide–Semaglutide in Adults with Overweight
Description
Your healthcare provider may recommend periodic evaluations to adjust your treatment plan and ensure maximum benefits from B12 therapy

10.1002/jbm.a.32191 29 ChuG.ShiC.WangH.ZhangW.YangH.LiB

Nausea (most common, especially during first 1 to 2 weeks of a new dose) Diarrhea or, just as often, constipation Vomiting (less common but more likely at 9 to 12 mg) Reduced appetite, food noise quieting down (this is the goal, not a side effect) Skin sensitivity (dysesthesia): tingling, prickly feeling, or sunburn-like skin

This causes cells to be very large and abnormally shaped

Future studies are needed to test the validity of these methods as potential rehabilitation treatments in humans [39]
